SUBSCRIBE

cirrhosis

FDA approves new treatment for hepatitis C

FDA approves new treatment for hepatitis C

August 3, 2017 – The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without…

Hepatorenal syndrome and large-volume paracentesis

Averting a Crisis. Takeaways  Hepatorenal syndrome (HRS), impaired renal function resulting from advanced liver disease, is characterized by renal vasoconstriction, systemic vasodilatation in the absence of other identifiable…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll